Randall A. Lipps net worth and biography

Randall Lipps Biography and Net Worth

CEO of Omnicell

Randall Lipps is Chairman, President, Chief Executive Officer, and founder of Omnicell. Under his leadership, Omnicell has grown from offering a single product to delivering the most comprehensive portfolio of medication management solutions across the continuum of care. The company is now building on its success in advanced automation, data intelligence, and expert services to fulfill its vision of the Autonomous Pharmacy.

Mr. Lipps founded Omnicell in 1992 after observing how inefficiently medical supplies were managed when his daughter was hospitalized at birth. Inspired by his work in airline industry operations and logistics, he sought to enable better management of supplies and medications in order to improve patient care.

Omnicell became a publicly traded company in August 2001, and today the company’s award-winning solutions are used in over 5,000 hospitals throughout the world and in over 40,000 institutional and retail pharmacies. Omnicell has been recognized as one of the top 150 Silicon Valley companies, as measured by market capitalization, by the San Jose Mercury News.

In 2014 Mr. Lipps was elected to the Bellwether League Hall of Fame. The Bellwether League is an industry organization that honors healthcare supply chain innovators, pioneers, and visionaries.

Mr. Lipps has made giving back to the community a priority at Omnicell, and the company has contributed funds and other assistance in response to natural disasters and to support other causes such as Mercy Ships, which delivers free healthcare to some of the poorest people in the world. Mr. Lipps and his wife, Kathy, have focused their own philanthropy on poverty, nursing and public education, pharmacy research, youth groups, and local community efforts.

What is Randall A. Lipps' net worth?: The estimated net worth of Randall A. Lipps is at least $10.96 million as of June 8th, 2023. Mr. Lipps owns 318,768 shares of Omnicell stock worth more than $10,956,375 as of March 26th. This net worth evaluation does not reflect any other assets that Mr. Lipps may own. Additionally, Mr. Lipps receives a salary of $1,850,000.00 as CEO at Omnicell. Learn More about Randall A. Lipps' net worth.
How old is Randall A. Lipps?: Mr. Lipps is currently 67 years old. There are 4 older executives and no younger executives at Omnicell. Learn More on Randall A. Lipps' age.
What is Randall A. Lipps' salary?: As the CEO of Omnicell, Inc., Mr. Lipps earns $1,850,000.00 per year. Learn More on Randall A. Lipps' salary.
How do I contact Randall A. Lipps?: The corporate mailing address for Mr. Lipps and other Omnicell executives is 590 EAST MIDDLEFIELD ROAD, MOUNTAIN VIEW CA, 94043. Omnicell can also be reached via phone at (877) 415-9990 and via email at ir@omnicell.com. Learn More on Randall A. Lipps' contact information.
Has Randall A. Lipps been buying or selling shares of Omnicell?: Randall A. Lipps has not been actively trading shares of Omnicell within the last three months. Most recently, on Thursday, June 8th, Randall A. Lipps bought 4,000 shares of Omnicell stock. The stock was acquired at an average cost of $73.76 per share, with a total value of $295,040.00. Following the completion of the transaction, the chief executive officer now directly owns 318,768 shares of the company's stock, valued at $23,512,327.68. Learn More on Randall A. Lipps' trading history.
Who are Omnicell's active insiders?: Omnicell's insider roster includes Joanne Bauer (Director), Dan Johnston (EVP), James Judson (Director), Peter Kuipers (CFO), Randall Lipps (CEO), Christine Mellon (EVP), Mark Parrish (Director), Scott Seidelmann (EVP), Robin Seim (Director), and Joseph Spears (CAO). Learn More on Omnicell's active insiders.
Are insiders buying or selling shares of Omnicell?: During the last year, insiders at the sold shares 1 times. They sold a total of 12,000 shares worth more than $567,600.00. The most recent insider tranaction occured on December, 10th when Director Mark W Parrish sold 12,000 shares worth more than $567,600.00. Insiders at Omnicell own 2.6% of the company. Learn More about insider trades at Omnicell.
Information on this page was last updated on 12/10/2024.

Randall A. Lipps Insider Trading History at Omnicell

Transaction Date	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
6/8/2023	Buy	4,000	$73.76	$295,040.00	318,768
12/1/2022	Sell	2,500	$50.78	$126,950.00	88,348
8/16/2022	Sell	13,000	$111.04	$1,443,520.00	302,049
12/8/2020	Sell	17,500	$110.56	$1,934,800.00	152,116
11/23/2020	Sell	15,000	$105.34	$1,580,100.00	152,116
11/20/2020	Sell	2,400	$105.01	$252,024.00	152,116
11/4/2020	Sell	11,435	$89.59	$1,024,461.65	152,116
9/15/2020	Sell	1,400	$75.01	$105,014.00	152,116
7/29/2020	Sell	3,718	$75.15	$279,407.70	152,116
4/3/2020	Sell	5,000	$66.11	$330,550.00	159,266
1/7/2020	Sell	24,000	$81.41	$1,953,840.00	116,466
11/21/2019	Sell	20,902	$78.75	$1,646,032.50	128,487
10/25/2019	Sell	1,172	$78.00	$91,416.00	128,487
10/21/2019	Sell	25,926	$78.03	$2,023,005.78	128,487
10/18/2019	Sell	5,000	$76.04	$380,200.00	140,506
7/25/2019	Sell	5,000	$70.30	$351,500.00	140,506
4/29/2019	Sell	65,161	$63.77	$4,155,316.97
4/29/2019	Sell	24,282	$79.01	$1,918,520.82
2/22/2019	Sell	20,000	$85.54	$1,710,800.00	194,793
12/18/2018	Sell	9,482	$63.89	$605,804.98	165,025
6/18/2018	Sell	439	$52.00	$22,828.00	211,323
3/6/2018	Sell	8,186	$44.21	$361,903.06	224,206
9/1/2017	Sell	10,625	$52.00	$552,500.00
8/1/2017	Sell	40,000	$49.76	$1,990,400.00	196,551
7/28/2017	Sell	37,500	$46.00	$1,725,000.00	196,551
6/19/2017	Sell	31,527	$42.87	$1,351,562.49	196,551
6/5/2017	Sell	9,900	$43.00	$425,700.00	208,982
4/25/2017	Sell	18,200	$41.00	$746,200.00	208,982
8/11/2016	Sell	37,425	$37.37	$1,398,572.25	192,325
2/11/2016	Sell	40,000	$27.81	$1,112,400.00	204,705
8/2/2013	Sell	25,000	$22.50	$562,500.00
7/19/2013	Sell	5,080	$21.00	$106,680.00
6/28/2013	Sell	25,000	$20.00	$500,000.00
6/18/2013	Sell	66,378	$19.10	$1,267,819.80

See Full Table

Randall A. Lipps Buying and Selling Activity at Omnicell

Omnicell Company Overview

Omnicell, Inc., together with its subsidiaries, provides medication management solutions and adherence tools for healthcare systems and pharmacies the United States and internationally. The company offers point of care automation solutions to improve clinician workflows in patient care areas of the healthcare system; XT Series automated dispensing systems for medications and supplies used in nursing units and other clinical areas of the hospital, as well as specialized automated dispensing systems for operating room; and robotic dispensing systems for handling the stocking and retrieval of boxed medications. It also provides central pharmacy automation solutions; IV compounding robots; and inventory management software. In addition, the company provides single-dose automation solutions that fill and label a variety of patient-specific, single-dose medication blister packaging based on incoming prescriptions; fully automated and semi-automated filling equipment for institutional pharmacies to warrant automated packaging of medications; and medication blister card packaging and packaging supplies to enhance medication adherence in non-acute care settings. Further, it offers EnlivenHealth Patient Engagement, a web-based solutions. The company was formerly known as Omnicell Technologies, Inc. and changed its name to Omnicell, Inc. in 2001. Omnicell, Inc. was incorporated in 1992 and is headquartered in Fort Worth, Texas.

Today's Range

Now: $34.45

$34.27

$34.70

50 Day Range

MA: $39.30

$32.28

$45.31

2 Week Range

Now: $34.45

$25.12

$55.75

Volume

306,662 shs

Average Volume

496,398 shs

Market Capitalization

$1.61 billion

P/E Ratio

127.60

Dividend Yield

N/A

Beta

0.85

Randall Lipps Biography and Net Worth

What is Randall A. Lipps' net worth?

How old is Randall A. Lipps?

What is Randall A. Lipps' salary?

How do I contact Randall A. Lipps?

Has Randall A. Lipps been buying or selling shares of Omnicell?

Who are Omnicell's active insiders?

Are insiders buying or selling shares of Omnicell?